MedPath

Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin

Phase 3
Completed
Conditions
Type 2 Diabetes Mellitus
Interventions
Registration Number
NCT03351478
Lead Sponsor
Lexicon Pharmaceuticals
Brief Summary

The purpose of the study is to demonstrate the superiority of sotagliflozin versus placebo on hemoglobin A1c (HbA1c) reduction in participants with type 2 diabetes (T2D) who have inadequate glycemic control on a DPP4(i) with or without metformin.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
770
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Empagliflozin 25 mgEmpagliflozinFollowing a 2-week run-in period, placebo matching sotagliflozin administered as two tablets (identical to sotagliflozin in appearance) and one capsule of empagliflozin 25 mg, once daily before the first meal of the day for up to 26 weeks.
Sotagliflozin 400 mgPlaceboFollowing a 2-week run-in period, sotagliflozin 400 mg (milligrams) administered as two 200 mg tablets and one placebo capsule (identical to the empagliflozin capsule in appearance), once daily before the first meal of the day for up to 26 weeks.
Empagliflozin 25 mgPlaceboFollowing a 2-week run-in period, placebo matching sotagliflozin administered as two tablets (identical to sotagliflozin in appearance) and one capsule of empagliflozin 25 mg, once daily before the first meal of the day for up to 26 weeks.
PlaceboPlaceboFollowing a 2-week run-in period, placebo was given as two placebo tablets (identical to sotagliflozin) and one placebo capsule (identical to empagliflozin) once daily before the first meal of the day for up to 26 weeks.
Sotagliflozin 400 mgSotagliflozinFollowing a 2-week run-in period, sotagliflozin 400 mg (milligrams) administered as two 200 mg tablets and one placebo capsule (identical to the empagliflozin capsule in appearance), once daily before the first meal of the day for up to 26 weeks.
Primary Outcome Measures
NameTimeMethod
Change From Baseline in Hemoglobin A1c (HbA1c) % at Week 26Baseline, Week 26

An analysis of covariance (ANCOVA) model was used for the analysis.

Secondary Outcome Measures
NameTimeMethod
Change From Baseline in Sitting Systolic Blood Pressure (SBP) at Week 12 in Participants With Baseline SBP ≥ 130 mmHgBaseline, Week 12

An ANCOVA model was used for the analysis.

Change From Baseline in 2-hour Postprandial Glucose (PPG) Following a Mixed Meal at Week 26Baseline, Week 26

An ANCOVA model was used for the analysis.

Change From Baseline in Fasting Plasma Glucose (FPG) at Week 26Baseline, Week 26

An ANCOVA model was used for the analysis.

Change From Baseline in Body Weight at Week 26Baseline, Week 26

An ANCOVA model was used for the analysis.

Change From Baseline in Sitting SBP at Week 12 for All ParticipantsBaseline, Week 12

An ANCOVA model was used for the analysis.

Percentage of Participants With HbA1c <6.5% at Week 26Week 26
Percentage of Participants With HbA1c <7.0% at Week 26Week 26

Trial Locations

Locations (160)

Investigational Site Number 8408010

🇺🇸

Knoxville, Tennessee, United States

Investigational Site Number 8408038

🇺🇸

Knoxville, Tennessee, United States

Investigational Site Number 1008005

🇧🇬

Ruse, Bulgaria

Investigational Site Number 1008002

🇧🇬

Smolyan, Bulgaria

Investigational Site Number 8408056

🇺🇸

Dallas, Texas, United States

Investigational Site Number 8408052

🇺🇸

Dallas, Texas, United States

Investigational Site Number 8408009

🇺🇸

Miami, Florida, United States

Investigational Site Number 8408001

🇺🇸

Houston, Texas, United States

Investigational Site Number 8408032

🇺🇸

Houston, Texas, United States

Investigational Site Number 8408016

🇺🇸

Houston, Texas, United States

Investigational Site Number 8408017

🇺🇸

Houston, Texas, United States

Investigational Site Number 8408035

🇺🇸

Birmingham, Alabama, United States

Investigational Site Number 8408067

🇺🇸

Van Nuys, California, United States

Investigational Site Number 8408028

🇺🇸

Sheffield, Alabama, United States

Investigational Site Number 8408047

🇺🇸

Hawaiian Gardens, California, United States

Investigational Site Number 8408031

🇺🇸

Spring Valley, California, United States

Investigational Site Number 8408069

🇺🇸

Northglenn, Colorado, United States

Investigational Site Number 8408049

🇺🇸

Ocoee, Florida, United States

Investigational Site Number 8408005

🇺🇸

Orlando, Florida, United States

Investigational Site Number 8408019

🇺🇸

Palmetto Bay, Florida, United States

Investigational Site Number 8408040

🇺🇸

Orlando, Florida, United States

Investigational Site Number 8408064

🇺🇸

Port Charlotte, Florida, United States

Investigational Site Number 8408061

🇺🇸

Columbus, Georgia, United States

Investigational Site Number 8408074

🇺🇸

Macon, Georgia, United States

Investigational Site Number 8408059

🇺🇸

Statesboro, Georgia, United States

Investigational Site Number 8408079

🇺🇸

Savannah, Georgia, United States

Investigational Site Number 8408002

🇺🇸

Rockville, Maryland, United States

Investigational Site Number 8408051

🇺🇸

Blackfoot, Idaho, United States

Investigational Site Number 8408033

🇺🇸

Elgin, Illinois, United States

Investigational Site Number 8408003

🇺🇸

New Orleans, Louisiana, United States

Investigational Site Number 8408044

🇺🇸

Fall River, Massachusetts, United States

Investigational Site Number 8408027

🇺🇸

West Seneca, New York, United States

Investigational Site Number 8408053

🇺🇸

Greensboro, North Carolina, United States

Investigational Site Number 8408037

🇺🇸

Fayetteville, North Carolina, United States

Investigational Site Number 8408012

🇺🇸

Greensboro, North Carolina, United States

Investigational Site Number 8408013

🇺🇸

Salisbury, North Carolina, United States

Investigational Site Number 8408045

🇺🇸

Oklahoma City, Oklahoma, United States

Investigational Site Number 8408068

🇺🇸

Warwick, Rhode Island, United States

Investigational Site Number 8408060

🇺🇸

Fort Mill, South Carolina, United States

Investigational Site Number 8408018

🇺🇸

Jefferson City, Tennessee, United States

Investigational Site Number 8408082

🇺🇸

Dallas, Texas, United States

Investigational Site Number 8408072

🇺🇸

Brownsville, Texas, United States

Investigational Site Number 8408036

🇺🇸

Houston, Texas, United States

Investigational Site Number 8408029

🇺🇸

Katy, Texas, United States

Investigational Site Number 8408022

🇺🇸

Houston, Texas, United States

Investigational Site Number 8408039

🇺🇸

Mesquite, Texas, United States

Investigational Site Number 8408054

🇺🇸

McAllen, Texas, United States

Investigational Site Number 8408042

🇺🇸

Plano, Texas, United States

Investigational Site Number 8408041

🇺🇸

Schertz, Texas, United States

Investigational Site Number 8408006

🇺🇸

Burke, Virginia, United States

Investigational Site Number 8408026

🇺🇸

Holladay, Utah, United States

Investigational Site Number 8408007

🇺🇸

Bountiful, Utah, United States

Investigational Site Number 8408004

🇺🇸

Manassas, Virginia, United States

Investigational Site Number 1008001

🇧🇬

Plovdiv, Bulgaria

Investigational Site Number 1008007

🇧🇬

Ruse, Bulgaria

Investigational Site Number 1008008

🇧🇬

Sofia, Bulgaria

Investigational Site Number 1008003

🇧🇬

Stara Zagora, Bulgaria

Investigational Site Number 1008012

🇧🇬

Sofia, Bulgaria

Investigational Site Number 1008010

🇧🇬

Stara Zagora, Bulgaria

Investigational Site Number 1008004

🇧🇬

Varna, Bulgaria

Investigational Site Number 1248007

🇨🇦

Burlington, Canada

Investigational Site Number 1248003

🇨🇦

Newmarket, Canada

Investigational Site Number 1248010

🇨🇦

Quebec, Canada

Investigational Site Number 1248001

🇨🇦

Brampton, Canada

Investigational Site Number 1248009

🇨🇦

Sherbrooke, Canada

Investigational Site Number 1248002

🇨🇦

Thornhill, Canada

Investigational Site Number 1248011

🇨🇦

Toronto, Canada

Investigational Site Number 1248008

🇨🇦

Victoriaville, Canada

Investigational Site Number 2038003

🇨🇿

Havirov, Czechia

Investigational Site Number 2038011

🇨🇿

Ostrava, Czechia

Investigational Site Number 2038006

🇨🇿

Pardubice, Czechia

Investigational Site Number 2038005

🇨🇿

Prague, Czechia

Investigational Site Number 2038010

🇨🇿

Plzen, Czechia

Investigational Site Number 2038002

🇨🇿

Praha 4, Czechia

Investigational Site Number 2038001

🇨🇿

Praha 10 - Uhrineves, Czechia

Investigational Site Number 2038013

🇨🇿

Praha 2, Czechia

Investigational Site Number 2038009

🇨🇿

Praha 1, Czechia

Investigational Site Number 2508005

🇫🇷

Corbeil-Essonnes, France

Investigational Site Number 2038008

🇨🇿

Praha 9, Czechia

Investigational Site Number 2508006

🇫🇷

La Roche Sur Yon, France

Investigational Site Number 2508007

🇫🇷

La Tronche, France

Investigational Site Number 2508003

🇫🇷

Mulhouse, France

Investigational Site Number 2508002

🇫🇷

Nantes Cedex 1, France

Investigational Site Number 2508001

🇫🇷

Paris, France

Investigational Site Number 3808010

🇮🇹

Catania, Italy

Investigational Site Number 2508004

🇫🇷

Saint-Mandé, France

Investigational Site Number 3808003

🇮🇹

Catania, Italy

Investigational Site Number 3808009

🇮🇹

Pavia, Italy

Investigational Site Number 3808005

🇮🇹

Milano, Italy

Investigational Site Number 3808004

🇮🇹

Milano, Italy

Investigational Site Number 3808001

🇮🇹

Roma, Italy

Investigational Site Number 3808008

🇮🇹

Roma, Italy

Investigational Site Number 7248006

🇪🇸

Barcelona, Spain

Investigational Site Number 7248002

🇪🇸

Córdoba, Spain

Investigational Site Number 8408011

🇺🇸

San Antonio, Texas, United States

Investigational Site Number 3808002

🇮🇹

Chieti, Italy

Investigational Site Number 1248004

🇨🇦

Toronto, Canada

Investigational Site Number 1248005

🇨🇦

Vancouver, Canada

Investigational Site Number 1008006

🇧🇬

Plovdiv, Bulgaria

Investigational Site Number 2038007

🇨🇿

Brandys, Czechia

Investigational Site Number 4848007

🇲🇽

Durango, Durango, Mexico

Investigational Site Number 7248005

🇪🇸

Malaga Malaga, Spain

Investigational Site Number 7248003

🇪🇸

Valencia Valencia, Spain

Investigational Site Number 1008011

🇧🇬

Gabrovo, Bulgaria

Investigational Site Number 2038004

🇨🇿

Krnov, Czechia

Investigational Site Number 4288008

🇱🇻

Limbazi, Latvia

Investigational Site Number 3808011

🇮🇹

San Giovanni Rotondo, Italy

Investigational Site Number 3808007

🇮🇹

Roma, Italy

Investigational Site Number 4288004

🇱🇻

Kuldiga, Latvia

Investigational Site Number 4288003

🇱🇻

Ogre, Latvia

Investigational Site Number 4288007

🇱🇻

Riga, Latvia

Investigational Site Number 4288001

🇱🇻

Riga, Latvia

Investigational Site Number 3808006

🇮🇹

Siena, Italy

Investigational Site Number 4288005

🇱🇻

Talsi, Latvia

Investigational Site Number 4848003

🇲🇽

Cuernavaca, Mexico

Investigational Site Number 4848001

🇲🇽

Monterrey, Mexico

Investigational Site Number 4848012

🇲🇽

Monterrey, Mexico

Investigational Site Number 6438008

🇷🇺

Chelyabinsk, Russian Federation

Investigational Site Number 4288002

🇱🇻

Riga, Latvia

Investigational Site Number 4288006

🇱🇻

Sigulda, Latvia

Investigational Site Number 4848002

🇲🇽

Chihuahua, Mexico

Investigational Site Number 6438003

🇷🇺

Saint-Petersburg, Russian Federation

Investigational Site Number 6438014

🇷🇺

St. Petersburg, Russian Federation

Investigational Site Number 7038003

🇸🇰

Vrutky, Slovakia

Investigational Site Number 4848011

🇲🇽

Mexico City, Mexico

Investigational Site Number 4848005

🇲🇽

Monterrey, Mexico

Investigational Site Number 6438006

🇷🇺

Dzerzhinsky, Russian Federation

Investigational Site Number 6438009

🇷🇺

Kemerovo, Russian Federation

Investigational Site Number 6438010

🇷🇺

Novosibirsk, Russian Federation

Investigational Site Number 6438013

🇷🇺

Saint-Petersburg, Russian Federation

Investigational Site Number 6438002

🇷🇺

Saint-Petersburg, Russian Federation

Investigational Site Number 6438005

🇷🇺

Saint-Petersburg, Russian Federation

Investigational Site Number 6438001

🇷🇺

Saint-Petersburg, Russian Federation

Investigational Site Number 6438012

🇷🇺

Saratov, Russian Federation

Investigational Site Number 6438015

🇷🇺

Volgograd, Russian Federation

Investigational Site Number 6438007

🇷🇺

Vsevolozhsk, Russian Federation

Investigational Site Number 6438011

🇷🇺

Yaroslavl, Russian Federation

Investigational Site Number 7038005

🇸🇰

Bardejov, Slovakia

Investigational Site Number 7038001

🇸🇰

Kosice, Slovakia

Investigational Site Number 7038009

🇸🇰

Bratislava, Slovakia

Investigational Site Number 8268002

🇬🇧

Huntingdon, United Kingdom

Investigational Site Number 8268003

🇬🇧

Southampton, United Kingdom

Investigational Site Number 7248001

🇪🇸

Sevilla, Spain

Investigational Site Number 7038006

🇸🇰

Lucenec, Slovakia

Investigational Site Number 7038008

🇸🇰

Nove Zamky, Slovakia

Investigational Site Number 7038004

🇸🇰

Povazska Bystrica, Slovakia

Investigational Site Number 7038002

🇸🇰

Roznava, Slovakia

Investigational Site Number 7038007

🇸🇰

Sabinov, Slovakia

Investigational Site Number 7248010

🇪🇸

Santa Coloma De Gramenet, Spain

Investigational Site Number 7248009

🇪🇸

Santiago De Compostela, Spain

Investigational Site Number 8268008

🇬🇧

Darlington, United Kingdom

Investigational Site Number 8268004

🇬🇧

Dundee, United Kingdom

Investigational Site Number 8268006

🇬🇧

Exeter, United Kingdom

Investigational Site Number 8268001

🇬🇧

Hull, United Kingdom

Investigational Site Number 8268007

🇬🇧

Sheffield, United Kingdom

Investigational Site Number 8268005

🇬🇧

Wolverhampton, United Kingdom

Investigational Site Number 7248004

🇪🇸

Sevilla, Spain

Investigational Site Number 7248007

🇪🇸

Zaragoza, Spain

Investigational Site Number 7248008

🇪🇸

Sevilla, Spain

Investigational Site Number 8408008

🇺🇸

Flint, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath